HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-(Chloromethyl)-5-methyl-1,3,4-oxadiazole → 5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-(5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-(Chloromethyl)-5-methyl-1,3,4-oxadiazole | HCID 3826620 | — |
| Reactant | 5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine | HCID 71558205 | — |
| Reactant | HCID 178441789 | HCID 178441789 | — |
| Product | 5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-(5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine | HCID 86683326 | — |
Reaction Steps
In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 61), the title compound was prepared from 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 2-(chloromethyl)-5-methyl-1,3,4-oxadiazole and isolated as colorless gum. MS(m/e): 379.3 (MH+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09056866B2 |
| Source dataset | uspto-grants-2015_06 |
| ORD ID | ord-56bcbbeb8f4a4c4e990ef6ab6fd534f1 |
| Source note | uspto-grants-2015_06 |